Literature DB >> 25296170

Array comparative genomic hybridisation testing in CHD.

Hannah B Hightower1, Nathaniel H Robin2, Fady M Mikhail2, Namasivayam Ambalavanan1.   

Abstract

BACKGROUND: CHD is the leading cause of mortality due to birth defects. Array comparative genomic hybridisation (aCGH) detects submicroscopic copy number changes and may improve identification of the genetic basis of CHD.
METHODS: This is a retrospective analysis of 1252 patients from a regional referral centre who had undergone aCGH. Of the patients, 173 had CHD. A whole-genome custom-designed oligonucleotide array with >44,000 probes was used to detect copy number changes.
RESULTS: Of the 1252 patients, 335 (26.76%) had abnormal aCGH results. Of the 173 patients with CHD, 50 (28.9%) had abnormal aCGH results versus 284 (26.3%) of 1079 non-cardiac patients. There were six patients with CHD who had well-described syndromes such as Wolf-Hirschhorn, trisomy 13, DiGeorge, and Williams. Of the patients with CHD, those with left-sided heart disease had the highest proportion (14/31; 45.13%) of abnormal aCGH results, followed by those with conotruncal heart disease (10/29; 34.48%), endocardial cushion defects (13/50; 26%), complex/other heart disease (12/52; 23.08%), and patent ductus arteriosus (1/11; 9.09%).
CONCLUSIONS: Patients with CHD are at a substantial risk of having microdeletions and microduplications. The incidence of abnormalities on aCGH analysis is higher than identified with karyotype, and identification of copy number changes may help identify the genetic basis of the specific heart defects. However, aCGH may not have a significant diagnostic yield in those with isolated CHD. Further research using larger data sets may help identify candidate genes associated with CHD.

Entities:  

Keywords:  CHD; array comparative genomic hybridisation (aCGH); copy number variants

Mesh:

Year:  2014        PMID: 25296170     DOI: 10.1017/S1047951114001838

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

1.  Major Contribution of Genomic Copy Number Variation in Syndromic Congenital Heart Disease: The Use of MLPA as the First Genetic Test.

Authors:  Rejane A C Monteiro; Mariana L de Freitas; Gabrielle S Vianna; Valdirene T de Oliveira; Rafaella X Pietra; Luana C A Ferreira; Patrícia P O Rocha; Michele da S Gonçalves; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Juliana F Mazzeu; Fernanda S Jehee
Journal:  Mol Syndromol       Date:  2017-06-14

2.  Cytogenomic Evaluation of Subjects with Syndromic and Nonsyndromic Conotruncal Heart Defects.

Authors:  Karen Regina de Souza; Rafaella Mergener; Janaina Huber; Lucia Campos Pellanda; Mariluce Riegel
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

Review 3.  The Outcome of Prenatally Diagnosed Isolated Fetal Ventricular Septal Defect.

Authors:  Shih-Yin Huang; An-Shine Chao; Chuan-Chi Kao; Chih-Hui Lin; Ching-Chang Hsieh
Journal:  J Med Ultrasound       Date:  2017-06-10

4.  Integration of Large-Scale Genomic Data Sources With Evolutionary History Reveals Novel Genetic Loci for Congenital Heart Disease.

Authors:  Elisavet Fotiou; Simon Williams; Alexandra Martin-Geary; David L Robertson; Gennadiy Tenin; Kathryn E Hentges; Bernard Keavney
Journal:  Circ Genom Precis Med       Date:  2019-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.